Paolini John F. — SEC insider filings
SEC reporting owner CIK 1741533. 36 insider filings on record with FilingPulse; latest filed 2026-11-17.
Transaction summary — filings shown
Covers all 36 filings on record, filed 2020-09-14 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 35 legs across 14 filings — 504,540 shares, $22,178,530 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 158.
- Largest priced transaction: sale of 41,789 shares @ $92.02 ($3,845,424) in Kiniksa Pharmaceuticals International, plc, filed 2026-11-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF MEDICAL OFFICER | 36 | — | 35 legs · 504,540 sh · $22,178,530 | 158 |
Insider filings — Paolini John F.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-17 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 29,670 @ $10.36 · Option exercise (M): 4,994 @ $11.10 · Option exercise (M): 3,723 @ $11.97 · Option exercise (M): 3,144 @ $12.97 · Option exercise (M): 2,595 @ $15.52 · Option exercise (M): 29,670 (derivative) @ $0 · +4 more | EDGAR |
| 2026-11-03 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 38,545 @ $30.93 · Option exercise (M): 39,042 @ $17.92 · Sale (S): 41,789 @ $92.02 · Sale (S): 16,056 @ $92.85 · Sale (S): 6,841 @ $93.91 · Sale (S): 4,821 @ $94.86 · +12 more | EDGAR |
| 2026-09-03 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 2,497 · Option exercise (M): 1,624 · Option exercise (M): 1,750 · Option exercise (M): 2,457 · Tax withholding (F): 4,029 @ $79.28 · Grant/award (A): 6,700 (derivative) @ $0 · +5 more | EDGAR |
| 2026-05-05 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 58,424 @ $10.36 · Sale (S): 37,327 @ $53.52 · Sale (S): 21,097 @ $54.04 · Option exercise (M): 58,424 (derivative) @ $0 | EDGAR |
| 2026-04-08 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 2,497 · Tax withholding (F): 1,208 @ $48.94 · Option exercise (M): 2,497 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 5,831 · Tax withholding (F): 2,821 @ $48.13 · Grant/award (A): 26,750 (derivative) @ $0 · Grant/award (A): 6,700 (derivative) @ $0 · Grant/award (A): 13,400 (derivative) @ $0 · Option exercise (M): 1,624 (derivative) @ $0 · +2 more | EDGAR |
| 2026-03-04 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 40,000 @ $10.36 · Sale (S): 12,063 @ $44.20 · Sale (S): 22,223 @ $44.88 · Sale (S): 5,714 @ $45.92 · Option exercise (M): 40,000 (derivative) @ $0 | EDGAR |
| 2025-11-04 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 36,542 @ $3.80 · Option exercise (M): 46,000 @ $8.83 · Sale (S): 82,542 @ $37.14 · Option exercise (M): 36,542 (derivative) @ $0 · Option exercise (M): 46,000 (derivative) @ $0 | EDGAR |
| 2025-09-03 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 1,750 · Option exercise (M): 1,624 · Option exercise (M): 2,498 · Tax withholding (F): 2,841 @ $33.49 · Option exercise (M): 1,725 · Tax withholding (F): 835 @ $34.28 · +6 more | EDGAR |
| 2025-08-08 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 29,325 @ $3.80 · Sale (S): 29,325 @ $32.55 · Option exercise (M): 29,325 (derivative) @ $0 | EDGAR |
| 2025-05-09 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 200 @ $3.80 · Sale (S): 200 @ $27 · Option exercise (M): 200 (derivative) @ $0 | EDGAR |
| 2025-05-05 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Grant/award (A): 4,954 (derivative) @ $0 · Grant/award (A): 5,201 (derivative) @ $0 · Grant/award (A): 8,007 (derivative) @ $0 · Grant/award (A): 8,266 (derivative) @ $0 | EDGAR |
| 2025-04-09 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 2,498 · Tax withholding (F): 734 @ $20.28 · Option exercise (M): 2,498 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 1,624 · Option exercise (M): 1,750 · Tax withholding (F): 477 @ $21.77 · Tax withholding (F): 514 @ $21.77 · Grant/award (A): 39,364 (derivative) @ $0 · Grant/award (A): 9,828 (derivative) @ $0 · +3 more | EDGAR |
| 2025-03-19 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 1,725 · Tax withholding (F): 507 @ $22.61 · Option exercise (M): 1,725 (derivative) @ $0 | EDGAR |
| 2024-09-04 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 4,121 · Tax withholding (F): 1,994 @ $26.74 · Option exercise (M): 1,725 · Tax withholding (F): 835 @ $26.74 · Option exercise (M): 60,217 @ $1.86 · Option exercise (M): 475 @ $3.80 · +9 more | EDGAR |
| 2024-07-25 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 22,000 @ $1.86 · Sale (S): 5,530 @ $25.03 · Sale (S): 7,924 @ $26.36 · Sale (S): 8,446 @ $27.10 · Sale (S): 100 @ $27.87 · Option exercise (M): 22,000 (derivative) @ $0 | EDGAR |
| 2024-04-08 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 2,497 · Tax withholding (F): 733 @ $17.90 · Grant/award (A): 36,350 (derivative) @ $0 · Grant/award (A): 5,600 (derivative) @ $0 · Grant/award (A): 7,000 (derivative) @ $0 · Option exercise (M): 2,497 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 1,624 · Tax withholding (F): 477 @ $19.70 · Option exercise (M): 1,624 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 18,844 @ $1.86 · Sale (S): 18,844 @ $21.77 · Option exercise (M): 18,844 (derivative) @ $0 | EDGAR |
| 2024-02-29 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 10,156 @ $1.86 · Sale (S): 10,156 @ $21.03 · Option exercise (M): 10,156 (derivative) @ $0 | EDGAR |
| 2023-12-11 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 28,600 @ $1.86 · Sale (S): 7,380 @ $17.54 · Sale (S): 13,017 @ $17.64 · Sale (S): 6,702 @ $17.75 · Sale (S): 1,501 @ $17.81 · Option exercise (M): 28,600 (derivative) @ $0 | EDGAR |
| 2023-09-06 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 2,498 · Tax withholding (F): 734 @ $17.76 · Option exercise (M): 1,725 · Tax withholding (F): 507 @ $17.76 · Option exercise (M): 400 @ $1.86 · Sale (S): 400 @ $17.53 · +5 more | EDGAR |
| 2023-07-27 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 29,000 @ $1.86 · Sale (S): 5,200 @ $18.01 · Sale (S): 16,168 @ $19.25 · Sale (S): 7,632 @ $19.69 · Option exercise (M): 29,000 (derivative) @ $0 | EDGAR |
| 2023-04-11 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 2,498 · Tax withholding (F): 734 @ $10.71 · Option exercise (M): 2,498 (derivative) @ $0 | EDGAR |
| 2023-04-03 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Grant/award (A): 38,974 (derivative) @ $0 · Grant/award (A): 6,496 (derivative) @ $0 | EDGAR |
| 2023-03-20 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 1,725 · Tax withholding (F): 507 @ $11.46 · Option exercise (M): 3,671 · Tax withholding (F): 1,078 @ $11.12 · Option exercise (M): 1,725 (derivative) @ $0 · Option exercise (M): 3,671 (derivative) @ $0 | EDGAR |
| 2022-11-09 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 28,357 @ $1.86 · Sale (S): 28,357 @ $15.18 · Option exercise (M): 28,357 (derivative) @ $0 | EDGAR |
| 2022-09-06 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 1,725 · Tax withholding (F): 507 @ $11.44 · Grant/award (A): 59,930 (derivative) @ $0 · Grant/award (A): 9,990 (derivative) @ $0 · Option exercise (M): 1,725 (derivative) @ $0 | EDGAR |
| 2022-04-11 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Grant/award (A): 59,930 (derivative) @ $0 · Grant/award (A): 9,990 (derivative) @ $0 | EDGAR |
| 2022-03-23 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 5,676 · Tax withholding (F): 1,686 @ $10.98 · Option exercise (M): 5,676 (derivative) @ $0 | EDGAR |
| 2022-03-18 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 1,725 · Tax withholding (F): 598 @ $10.13 · Option exercise (M): 1,725 (derivative) @ $0 | EDGAR |
| 2021-09-07 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Grant/award (A): 41,400 (derivative) @ $0 · Grant/award (A): 6,900 (derivative) @ $0 | EDGAR |
| 2021-03-23 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Grant/award (A): 5,676 (derivative) @ $0 · Grant/award (A): 3,671 (derivative) @ $0 | EDGAR |
| 2021-03-18 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Grant/award (A): 41,400 (derivative) @ $0 · Grant/award (A): 6,900 (derivative) @ $0 | EDGAR |
| 2020-09-14 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1741533 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs